2019 Speakers

 

 

 

Kamal Amin, Senior Clinical Supply Manager, Fujifilm Kyowa Kirin Biologics, United Kingdom

Dr. Hema Bajaj, India Multicountry Quality Head, Sanofi, India

Lynne Baxter, Senior Clinical Study Researcher, Global ELN Centre of Excellence Clinical Research, Danone Nutriticia Research, Singapore

Lynne Baxter at Phar-East 2019

Mario Bertazzoli, Director, Head Corporate Drug Safety, Helsinn SA, Switzerland

Antonio Bertoletti, Co-Founder, Lion TCR, Singapore

James Cai, VP, Global Regulatory Affairs for JAPAC, Amgen, Hong Kong

Hardy Chan, Founder and Chairman, Allianz Pharmascience, Taiwan

Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo Pharma, India

Yi-Chun Maria Chen, Director of Business Development, Immunwork Inc., Taiwan

Yi-Chun Maria Chen at Phar-East 2019

Meng Chi Chen, Director Business Development, BRIM Biotechnology, Taiwan

Meng Chi Chen at Phar-East 2019

Seong-Choon Choe, Head, Seoul Research Institute, Boryung Pharmaceutical, Republic Of Korea

Harish Dave, Chief Medical Officer, AUM Biosciences, Singapore

Vishal Doshi, CEO, AUM Biosciences, Singapore

Nick Ede, Chief Technology Officer, Imugene Ltd, Australia

Carl Firth, Chief Executive Officer, ASLAN Pharmaceuticals, Singapore

James Garner, Chief Executive Officer & Managing Director, Kazia Therapeutics Limited, Australia

Anand Gautam, Senior Director and Head, External Science & Innovation, ANZ & SEA, Pfizer, Australia

Stewart Geary, Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters, Eisai, Japan

Mayank Gurnani, Associate Professor, Industry Liaison Office, National University of Singapore, Singapore

Mayank Gurnani at Phar-East 2019

Shwen Gwee, General Manager, Digital Accelerator (Global Drug Development), Novartis, United States

Vicky Han, Senior Director, Regulatory Policy Group Lead for Asia Pacific, Janssen Pharmaceuticals, Singapore

Jeonghoon Han, Vice President, Chief Development and Technology Officer, Eutilex Ltd, Republic Of Korea

Carrie Hillyard, Chairman, FitGenes, Australia

Nomura Hironoshin, Pharmaceuticals, Biotech, OTC & Small companies, Mizuho Securities, Japan

Piers Ingram, CEO, Hummingbird Bioscience, Singapore

Mrunalini Jagtap, Data Management Lead, SICS, A*STAR, Singapore

William Jia, CSO, Virogin Biotech, China

Soekjoong Kim, Board Member, Director and Head of Business Development, Toolgen, Republic Of Korea

George Kopsidas, Executive Director, Imunexus, Australia

David Lane, Chief Scientist, Agency for Science Technology and Research (A*STAR), Singapore

Victor Li, CEO, Lion TCR, Singapore

Sook Yee Lim, Vice President, Malaysian Rare Disorders Society, Malaysia

Maggie Lim, Clinical Development Quality Assurance (Asia-Pacific), Global Quality & Compliance, GSK Pte Ltd, Singapore

Edmund Lim, Co-founder, We CARE Journey, Malaysia

Xiangqian Lin, Managing Partner, Esco Ventures, United Kingdom

Liping Liu, CEO & CSO, Shenzhen HighTide Biopharmaceutical Ltd., China

Hui Hsing Ma, Senior Advisor, TVM Capital Healthcare Partners, Germany

Alex Matter, Executive Director, D3, Agency for Science Technology & Research, Singapore

Joseph Mocanu, Managing Director, Verge Capital Management, Singapore

Sabrina Ng, CFO, Hummingbird Bioscience, Singapore

Yongho Oh, Regional Clinical Project Manager & ISS Project Manager, JPAC and China, Sanofi, Singapore

Siew Hwa Ong, Chairman, BioSingapore, Singapore

Anil Pareek, President, Medical Affairs and Clinical Research, Ipca Laboratories Ltd, India

Anil Pareek at Phar-East 2019

Chongdeok Park, Chief Development Officer, Kolon Pharmaceuticals, Republic Of Korea

Hung Fai Poon, President, QuaCell Biotech Ltd, China

Gopal Rao, Global Business Development and Services Outsourcing, Biotech Division Lupin Ltd, India

Dr Gs Reddy, Chief General Manager, Manufacturing, Indian Immunologicals Ltd, India

Byung-Geon (BG) Rhee, CEO, SCM Lifescience, Republic Of Korea

Dr Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute, Republic Of Korea

Dr Sushant Sahastrabuddhe at Phar-East 2019

Benjamin Seet, Executive Director, Biomedical Sciences Institute A*STAR, Singapore

Sam Shen, QA Director, Fosun Kite Biotechnology, China

Mohd Fazli Shuib, Head, Pharmacy Services, F.V. Hospital, Vietnam

Mohd Fazli Shuib at Phar-East 2019

Dwo Yuan Sia, Chief Technology Officer, BravoVax Co Ltd, China

Charles Stacey, President and Chief Executive Officer, Accera Inc, United States

Crystal Sun, CEO Assistant & Director, Regulatory & Government Affairs, Fosun Kite Biotechnology, China

Haolin Sung, Director, Direct Investment, Diamond BioFund, Taiwan

Haolin Sung at Phar-East 2019

Nadia Suttikulpanich, Head of Fuchsia Innovation Center for Muang Thai Life Assurance, Muang Thai Life Assurance Public Company, Thailand

Nadia Suttikulpanich at Phar-East 2019

I-Ning Tang, Senior Reviewer & Team Leader, Center For Drug Evaluation, Taiwan

Gavin Teo, Partner, B Capital Group, United States

Sophie Tsou, Associate Investigator, Division of Biostatistics and Bioinformatics, National Health Research Institutes, Taiwan

Salah Uddin, Assistant Director, DGDA Bangladesh, Bangladesh

Salah Uddin at Phar-East 2019

Judith Walker, Chief Medical Officer, Accera Pharma, United Kingdom

Judith Walker at Phar-East 2019

Kum Cheun Wong, Head Asia Pacific Policy and Liaison, Drug Regulatory Affairs, Novartis Asia Pacific, Singapore

Kum Cheun Wong at Phar-East 2019

Jeffry Wu, Managing Director, Milestone Capital Management Ltd., China

Jeffry Wu at Phar-East 2019

Jing Ping Yeo, Director, Research Integrity, Compliance, Ethics, Singapore Health Services (SingHealth), Singapore

Robert Wonsang Yu, Vice President, Yuyu Pharma, Republic Of Korea

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group, China

 

 

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738